HES
53
4
ADSK
63
2
MCO
73
5
NDAQ
50
4
VTR
46
3
QCOM
59
3
AON
30
2
BF.B
35
2
TGT
47
3
KO
46
4
CME
61
2
INTU
57
3
SIG
55
3
CFG
40
4
KHC
15
4
GWW
51
3
MS
70
6
MCHP
37
3
KMB
31
3
DAL
64
3
HES
53
4
ADSK
63
2
MCO
73
5
NDAQ
50
4
VTR
46
3
QCOM
59
3
AON
30
2
BF.B
35
2
TGT
47
3
KO
46
4
CME
61
2
INTU
57
3
SIG
55
3
CFG
40
4
KHC
15
4
GWW
51
3
MS
70
6
MCHP
37
3
KMB
31
3
DAL
64
3
Financhill
Back

Harmony Biosciences Holdings 10K Form

Sell
31

HRMY
Harmony Biosciences Holdings

Last Price:
$33.65
Seasonality Move:
-6.84%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRMY News And Ratings

See the #1 stock for the next 7 days that we like better than HRMY

HRMY Financial Statistics

Sales & Book Value

Annual Sales: $582M
Cash Flow: $70.5M
Price / Cash Flow: 8.97
Annual Sales: $10.46
Price / Book: 3.25

Profitability

EPS (TTM): 2.11000
Net Income (TTM): $122.6M
Gross Margin: $460.8M
Return on Equity: 23.59%
Return on Assets: 14.52%

Harmony Biosciences Holdings Earnings Forecast

Key Harmony Biosciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 6 years for HRMY is 79.17%.
  • The Selling, General & Administrative Expenses for HRMY have been equal to 33.11% of Gross Profit Margin.
  • The Research & Development expenses have been 13.07% of Revenue.
  • The Interest Expense is 18.44% of Operating Income.
  • The Net Earning history of HRMY is 22.14% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Harmony Biosciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HRMY
Website: harmonybiosciences.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 3.24
Quick Ratio: 3.05

Price-to-Earnings

Trailing P/E Ratio: 15.99
Forward P/E Ratio: 7.78

HRMY Technical Analysis vs Fundamental Analysis

Sell
31
Harmony Biosciences Holdings (HRMY) is a Sell

Is Harmony Biosciences Holdings a Buy or a Sell?